Prøve GULL - Gratis

Health

Chronicle Pharmabiz

AP Pharma JAC enforces strict membership integrity ahead of council polls

THE Andhra Pradesh Pharma Joint Action Committee (AP Pharma JAC), a powerful coalition of pharmacist associations, has taken a decisive action to secure its internal integrity just weeks before the contentious Andhra Pradesh Pharmacy Council (APPC) elections.

1 min  |

November 27, 2025

Chronicle Pharmabiz

AstraZeneca, Sun Pharma to help hyperkalaemia patients

A STRAZENECA Pharma India and Sun Pharmaceutical Industries (Sun) announced a second brand partnership for sodium zirconium cyclosilicate (SZC) in India.

1 min  |

November 27, 2025

Chronicle Pharmabiz

Councils asked to comply with norms in appointment of registrars

THE Pharmacy Council of India (PCI) has asked the State Pharmacy Councils to strictly comply with the regulations related to the qualifications while appointing registrar in their respective Councils.

2 min  |

November 27, 2025

Chronicle Pharmabiz

Dept of Consumer Affairs unveils e-portal to recognise pvt labs as approved test units

THE Department of Consumer Affairs, under the ministry of consumer affairs, food and public distribution has launched an online portal for private industries, laboratories, and testing facilities to apply for recognition as Government Approved Test Centres (GATC).

2 min  |

November 27, 2025

Chronicle Pharmabiz

BDCDA protests against GSK's circular on expired drugs

THE Bangalore District Chemists and Druggists Association (BDCDA) has strongly objected and is protesting against the GSK's circular dated November 5, 2025, on return of expired/unused drugs within 30 days of expiry - a misinterpretation of CDSCO guidance document: WI/01/DCC-P-25.

1 min  |

November 27, 2025

Chronicle Pharmabiz

Industry stresses on tie-ups and indigenous sourcing

THE Indian pharmaceutical industry is stressing on the need to draw on the advantages of backward integration, partnerships and internal sourcing to reduce import dependence.

2 min  |

November 27, 2025

Chronicle Pharmabiz

KSMSC tightens drug procurement with sampling measures

THE Karnataka State Medical Supplies Corporation (KSMSC), the nodal agency for procurement of medicines, consumables and equipment for hospitals across the 31 districts in the state, had implemented a comprehensive quarantine and sampling framework aimed at strengthening quality assurance and accountability across its supply chain.

2 min  |

November 27, 2025

Chronicle Pharmabiz

India is a strategic innovation engine for lifesciences: Expert

GLOBAL life sciences industry is experiencing a period of extraordinary transformation.

2 min  |

November 27, 2025

Chronicle Pharmabiz

Govt notifies recruitment of 32 drug inspectors

THe Union Ministry of Health and Family Welfare has notified recruitment of 32 drug inspectors under the Central Drugs Standard Control Organisation (CDSCO), as part of strengthening the organisation's operations to regulate the drugs, medical devices and cosmetics industry and monitor the market in the country.

1 min  |

November 27, 2025
Chronicle Pharmabiz

Chronicle Pharmabiz

Lactose India unveils new specialized grades

IN a significant boost to India’s pharmaceutical sector, Lactose India Ltd (LIL) has launched a new lineup of specialized lactose grades, marking a pivotal advancement in the country’s domestic production capabilities.

3 min  |

November 27, 2025

Chronicle Pharmabiz

GenAI propels data-driven clinical decision-making: Expert

HEALTHCARE systems are maximizing Generative AI (GenAI) to enhance diagnostic accuracy, optimize clinical workflows, and enable precision-guided therapeutics, said Ganesh Nathella, Executive Vice President and General Manager - HLS Business at Persistent Systems.

2 min  |

November 27, 2025

Chronicle Pharmabiz

Exclusive Ministry for Pharmaceuticals

FROM a 100 per cent importer of medicines till the 1970s to the exporter of medicines to around 200 countries, including the developed markets like the US, EU, Japan, etc, the Indian pharmaceutical industry has indeed come a long way to adorn the epithet of 'the pharmacy of the world'.

2 min  |

November 27, 2025

Chronicle Pharmabiz

DGFT resolves concern to redemption of AAs affected by old CGST

In a significant relief for pharmaceutical exporters, the Directorate General of Foreign Trade (DGFT) has issued a clarification resolving a longstanding concern related to the redemption of Advance Authorisations (AAs) impacted by the erstwhile Rule 96(10) of the CGST Rules-2017.

2 min  |

November 27, 2025

Chronicle Pharmabiz

Panel recommends DoP to keep control over prices of stents

THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DoP) and the National Pharmaceutical Pricing Authority (NPPA) to look into the increase in prices of stents and bring it down, along with strict monitoring to curb overcharging.

2 min  |

November 27, 2025

Chronicle Pharmabiz

'Indian pharma's fundamentals signal shift towards science-driven models'

THE Indian pharmaceutical industry's defining trend currently is the shift from volume-led growth to valueand innovation-led expansion.

1 min  |

November 20, 2025

Chronicle Pharmabiz

Rejection of trial waiver for Hetero's lenacapavir will impact India, LMICS: TWN

THE decision of the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to reject Hetero Lab's request for waiver of two studies for the manufacturing and marketing of generic lenacapavir 300 mg tablet will impact the accessibility of the generic equivalent of Gilead's HIV drug in India and the low-and-middle income countries (LMICs), according to an independent nonprofit international research and advocacy organisation.

3 min  |

November 20, 2025

Chronicle Pharmabiz

APPC election hit by allegations

As preparations for the Andhra Pradesh Pharmacy Council (APPC) elections 2025 are underway, various panels are busy finalizing their candidates, setting the stage for a charged contest over the future governance of the state's pharmacy profession.

1 min  |

November 20, 2025

Chronicle Pharmabiz

ICMR lists important pathogens causing critical infections

THE Division of Communicable Diseases of Indian Council of Medical Research (ICMR) has listed important pathogens causing critical infectious syndromes in India to guide patient management, public health policies, and biomedical research and development (R&D).

2 min  |

November 20, 2025

Chronicle Pharmabiz

ICMR invites EoIs for data contribution for pregnancy cohort studies

IN order to understand hypothyroidism during pregnancy among Indian women, the Indian Council of Medical Research (ICMR) has invited Expression of Interests (Eols) from researchers and institutions to contribute data from ongoing or completed pregnancy cohort studies or randomized controlled trials (RCTs).

2 min  |

November 20, 2025

Chronicle Pharmabiz

Alembic gets US FDA final approval for diltiazem tablets.

ALEMBIC Pharmaceuticals A Limited (Alembic), a verti cally integrated research and development pharmaceutical company, announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) diltiazem hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

1 min  |

November 20, 2025

Chronicle Pharmabiz

A Scheme to Unleash Innovation Potential

THE Department of Pharmaceuticals (DoP) has recently notified the amendments to the Rs. 5,000 crore Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme which will build an advanced R&D infrastructure across the country.

2 min  |

November 20, 2025

Chronicle Pharmabiz

Alkem Lab reports 17% revenue growth in Q2 FY26

ALKEM Laboratories Ltd. to report and consolidated financial results for the second quarter ended September 30, 2025. The board of directors took record of these results at its meeting held in Mumbai today.

1 min  |

November 20, 2025

Chronicle Pharmabiz

IP gets recognition as book of standards in 17 countries

THE Indian Pharmacopoeia (IP) as a book of standards for medicines has been recognized by 17 countries till date. This will ensure quality medicines being manufactured and/or imported in the respective foreign countries and hence boost exports.

2 min  |

November 20, 2025

Chronicle Pharmabiz

Ghaziabad-based IPC inks MoU with TNPC

THE Ghaziabad-based Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with the Tamil Nadu Pharmacy Council (TNPC) to promote safe and rational use of medicines through joint initiatives in pharmacovigilance, patient safety, and professional awareness among pharmacists.

1 min  |

November 20, 2025

Chronicle Pharmabiz

Aurobindo Pharma net profit up 3.8% in Q2

AUROBINDO Pharma, a second largest Indian pharma Company with revenues of Rs. 31,700 crore plus, has posted single digit growth in revenues as well as profits during the second quarter ended September 2025. Its consolidated revenue increased by 6.3 per cent to Rs.8,286 crore from Rs. 7,796 crore in the corresponding period of ast year.

1 min  |

November 20, 2025

Chronicle Pharmabiz

Novo Nordisk's Wegovy price slash a game-changer for obesity: BDCDA

THE Bangalore District Chemists and Druggists welcomed Novo Nordisk's decision to reduce the price of its anti-obesity medication, Wegovy, by up to 37%.

2 min  |

November 20, 2025

Chronicle Pharmabiz

KSMSC to procure ₹800 cr of medicines with strict quality control

THE Karnataka State Medical Supplies Corporation (KSMSC) is now all set to procure tenders for pharmaceutical supplies, potentially worth Rs. 800 crore, with a focus on stringent quality control measures. The corporation had earlier invited tenders for 100 drugs worth Rs. 485 crore. All this would include multiple checks and testing for each batch of drugs to ensure the highest standards are maintained.

2 min  |

November 20, 2025

Chronicle Pharmabiz

GLS gets US FDA nod for Hyderabad unit

RANULES India's wholly owned subsidiary, Granules Life Sciences (GLS), located in Hyderabad has received US Food and Drug Administration (FDA) approval for a product that was the subject of a Pre- Approval Inspection (PAI) conducted between July 28 and August 1, 2025.

1 min  |

November 20, 2025

Chronicle Pharmabiz

Glasgow Univ's bioengineered bone marrow used in leukaemia research

UNIVERSITY of Glasgow rely used the first bioengineered bone marrow model to carry out vital cancer research, offering new insights into potential therapies for the disease.

2 min  |

November 20, 2025

Chronicle Pharmabiz

Botswana becomes 18th country to recognize IP

BOTSWANA has become the 18th country to officially sign a memorandum of understanding (MoU) to recognize Indian Pharmacopoeia (IP) as a book of standards for medicines. This recognition of IP in Botswana will remove double regulation, duplication in testing and post importation checks. This will further facilitate easier access to quality and affordable Indian medicines in Botswana and hence boost Indian pharma exports.

1 min  |

November 20, 2025